Experic Engages with Inhalation Leaders at RDD 2026
Experic recently participated in RDD 2026, held May 10–14 in Phoenix, Arizona, where industry leaders gathered to discuss the latest advancements in inhalation and nasal drug development.
Representing Experic at the event were:
- Jeffrey Shane, Chief Commercial Officer
- Justin Lacombe, Ph.D., Chief Scientific Officer
- Jason Chen, Business Development Manager
Throughout the conference, the team connected with sponsors and partners to explore evolving challenges in inhalation product development, including formulation strategies, spray drying, and the path to GMP manufacturing and clinical supply.
Events like RDD provide valuable opportunities to exchange insights and collaborate with innovators working to advance complex inhalation and nasal therapies. Experic remains committed to supporting these programs with the speed, flexibility, and technical expertise needed to move from development through clinical execution.
Interested in continuing the conversation?
Contact our team to learn how Experic can support your next program.